The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Rational Design of Potent Antagonists to the Human Growth Hormone Receptor
Abstract
A hybrid receptor was constructed that contained the extracellular binding domain of the human growth hormone (hGH) receptor linked to the transmembrane and intracellular domains of the murine granulocyte colony-stimulating factor receptor. Addition of hGH to a myeloid leukemia cell line (FDC-P1) that expressed the hybrid receptor caused proliferation of these cells. The mechanism for signal transduction of the hybrid receptor required dimerization because monoclonal antibodies to the hGH receptor were agonists whereas their monovalent fragments were not. Receptor dimerization occurs sequentially—a receptor binds to site 1 on hGH, and then a second receptor molecule binds to site 2 on hGH. On the basis of this sequential mechanism, which may occur in many other cytokine receptors, inactive hGH analogs were designed that were potent antagonists to hGH-induced cell proliferation. Such antagonists could be useful for treating clinical conditions of hGH excess, such as acromegaly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Kunkel, T. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.488 · Cited by 7,206
[19] Rapid and efficient site-specific mutagenesis without phenotypic selection
Kunkel, T. A., Roberts, J. D., & Zakour, R. A. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)54085-x · Cited by 5,261
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,239
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069
Growth hormone receptor and serum binding protein: purification, cloning and expression
Leung, D. W., Spencer, S. A., Cachianes, G., Hammonds, R. G., Collins, C., Henzel, W. J., Barnard, R., Waters, M. J., & Wood, W. I. (1987) · Nature · doi:10.1038/330537a0 · Cited by 1,522
High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis
Cunningham, B. C., & Wells, J. A. (1989) · Science · doi:10.1126/science.2471267 · Cited by 1,367
Self-citationCunningham, B. C., Ultsch, M., de Vos, A. M., Mulkerrin, M. G., Clauser, K. R., & Wells, J. A. (1991) · Science · doi:10.1126/science.1948064 · Cited by 874
Self-citationA new cytokine receptor superfamily
Cosman, D., Lyman, S. D., Idzerda, R. L., Beckmann, M. P., Park, L. S., Goodwin, R. G., & March, C. J. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90051-c · Cited by 476
Melmed, S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221405 · Cited by 438
Expression cloning of a receptor for murine granulocyte colony-stimulating factor
Fukunaga, R., Ishizaka-Ikeda, E., Seto, Y., & Nagata, S. (1990) · Cell · doi:10.1016/0092-8674(90)90814-u · Cited by 345
Self-citation
Cited by
A Hot Spot of Binding Energy in a Hormone-Receptor Interface
Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,983
Self-citationDimerization of cell surface receptors in signal transduction
Heldin, C.-H. (1995) · Cell · doi:10.1016/0092-8674(95)90404-2 · Cited by 1,634
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-7 Receptor
Noguchi, M., Nakamura, Y., Russell, S. M., Ziegler, S. F., Tsang, M., Cao, X., & Leonard, W. J. (1993) · Science · doi:10.1126/science.8266077 · Cited by 1,109
Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.-J., Broger, C., Loetscher, H., & Lesslauer, W. (1993) · Cell · doi:10.1016/0092-8674(93)90132-a · Cited by 1,104
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Trainer, P. J., Drake, W. M., Katznelson, L., Freda, P. U., Herman-Bonert, V., van der Lely, A. J., Dimaraki, E. V., Stewart, P. M., Friend, K. E., Vance, M. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421604 · Cited by 879
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
Waxman, D. J., & Holloway, M. G. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056705 · Cited by 815
Identification of molecular apocrine breast tumours by microarray analysis
Farmer, P., Bonnefoi, H., Becette, V., Tubiana-Hulin, M., Fumoleau, P., Larsimont, D., MacGrogan, G., Bergh, J., Cameron, D., Goldstein, D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208561 · Cited by 785
Soluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
Diet-induced obese mice develop peripheral, but not central, resistance to leptin.
Van Heek, M., Compton, D. S., France, C. F., Tedesco, R. P., Fawzi, A. B., Graziano, M. P., Sybertz, E. J., Strader, C. D., & Davis, H. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119171 · Cited by 752
IL-6-Induced Homodimerization of gp130 and Associated Activation of a Tyrosine Kinase
Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T., & Kishimoto, T. (1993) · Science · doi:10.1126/science.8511589 · Cited by 724
Spivak-Kroizman, T., Lemmon, M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J., & Lax, I. (1994) · Cell · doi:10.1016/0092-8674(94)90032-9 · Cited by 658
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
van der Lely, A. J., Hutson, R. K., Trainer, P. J., Besser, G. M., Barkan, A. L., Katznelson, L., Klibanski, A., Herman-Bonert, V., Melmed, S., Vance, M. L., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06844-1 · Cited by 645
FDA-approved poly(ethylene glycol)–protein conjugate drugs
Alconcel, S. N. S., Baas, A. S., & Maynard, H. D. (2011) · Polymer Chemistry · doi:10.1039/c1py00034a · Cited by 643
Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-4 Receptor
Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C., Miyajima, A., Puri, R. K., Paul, W. E., et al. (1993) · Science · doi:10.1126/science.8266078 · Cited by 605
Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å
Livnah, O., Stura, E. A., Johnson, D. L., Middleton, S. A., Mulcahy, L. S., Wrighton, N. C., Dower, W. J., Jolliffe, L. K., & Wilson, I. A. (1996) · Science · doi:10.1126/science.273.5274.464 · Cited by 588
Structural biology of insulin and IGF1 receptors: implications for drug design
De Meyts, P., & Whittaker, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd917 · Cited by 582
The insulin signalling system and the IRS proteins
White, M. F. (1997) · Diabetologia · doi:10.1007/s001250051387 · Cited by 581
Regulation of signal transduction and signal diversity by receptor oligomerization
Lemmon, M. A., & Schlessinger, J. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90130-9 · Cited by 477
Binding in the growth hormone receptor complex.
Wells, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.1 · Cited by 438
Self-citationMechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor
Brooks, A. J., Dai, W., O’Mara, M. L., Abankwa, D., Chhabra, Y., Pelekanos, R. A., Gardon, O., Tunny, K. A., Blucher, K. M., Morton, C. J., et al. (2014) · Science · doi:10.1126/science.1249783 · Cited by 418
The alphas, betas, and kinases of cytokine receptor complexes
Stahl, N., & Yancopoulos, G. D. (1993) · Cell · doi:10.1016/0092-8674(93)90506-l · Cited by 405
The X-ray structure of a growth hormone–prolactin receptor complex
Somers, W., Ultsch, M., De Vos, A. M., & Kossiakoff, A. A. (1994) · Nature · doi:10.1038/372478a0 · Cited by 393
Interleukin‐6: Structure‐function relationships
Simpson, R. J., Hammacher, A., Smith, D. K., Matthews, J. M., & Ward, L. D. (1997) · Protein Science · doi:10.1002/pro.5560060501 · Cited by 371
Model for growth hormone receptor activation based on subunit rotation within a receptor dimer
Brown, R. J., Adams, J. J., Pelekanos, R. A., Wan, Y., McKinstry, W. J., Palethorpe, K., Seeber, R. M., Monks, T. A., Eidne, K. A., Parker, M. W., et al. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb977 · Cited by 368
Two EGF molecules contribute additively to stabilization of the EGFR dimer
Lemmon, M. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.281 · Cited by 367
The growth hormone receptor: mechanism of activation and clinical implications
Brooks, A. J., & Waters, M. J. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.123 · Cited by 357
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
Kopchick, J. J., Parkinson, C., Stevens, E. C., & Trainer, P. J. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0022 · Cited by 352
Insulin and its receptor: structure, function and evolution
De Meyts, P. (2004) · BioEssays · doi:10.1002/bies.20151 · Cited by 345
Clark, R. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.2.0296 · Cited by 314
“The prospective availability of a GH antagonist (80, 81) provides the opportunity to antagonize both local and systemic hGH.”
BackgroundInfluentialMolecular Mechanism of Growth Hormone Action
Carter-Su, C., Schwartz, J., & Smit, L. J. (1996) · Annual Review of Physiology · doi:10.1146/annurev.ph.58.030196.001155 · Cited by 311
Dehkhoda, F., Lee, C. M. M., Medina, J., & Brooks, A. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00035 · Cited by 304
Insights into Cytokine–Receptor Interactions from Cytokine Engineering
Spangler, J. B., Moraga, I., Mendoza, J. L., & Garcia, K. C. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120211 · Cited by 304
T cell receptor antagonists and partial agonists
Jameson, S. C., & Bevan, M. J. (1995) · Immunity · doi:10.1016/1074-7613(95)90074-8 · Cited by 298
GOFFIN, V., SHIVERICK, K. T., KELLY, P. A., & MARTIAL, J. A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-385 · Cited by 293
De Meyts, P. (1994) · Diabetologia · doi:10.1007/bf00400837 · Cited by 285
Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications
Banerjee, S. S., Aher, N., Patil, R., & Khandare, J. (2012) · Journal of Drug Delivery · doi:10.1155/2012/103973 · Cited by 282
Clackson, T., Ultsch, M. H., Wells, J. A., & de Vos, A. M. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1669 · Cited by 278
Self-citationFukunaga, R., Ishizaka-Ikeda, E., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90729-a · Cited by 275
Self-citationFuh, G., Li, B., Crowley, C., Cunningham, B., & Wells, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11197 · Cited by 259
Self-citationCytokine structural taxonomy and mechanisms of receptor engagement
Sprang, S. R., & Fernando Bazan, J. (1993) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(93)90144-a · Cited by 256
Dissecting the thrombopoietin receptor: Functional elements of the Mpl cytoplasmic domain
Drachman, J. G., & Kaushansky, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2350 · Cited by 153
Veldhuis, J. D., Bidlingmaier, M., Anderson, S. M., Evans, W. S., Wu, Z., & Strasburger, C. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011885 · Cited by 61
Engineering an interfacial zinc site to increase hormone-receptor affinity
Matthews, D. J., & Wells, J. A. (1994) · Chemistry & Biology · doi:10.1016/1074-5521(94)90037-x · Cited by 12
Self-citationA comprehensive kinetic model for ternary complex catalysis
Douglass Jr., E. F., & Miller, C. J. (2022) · doi:10.26434/chemrxiv-2021-wgn82-v2 · Cited by 7
Metadata
- Authors
- Fuh, G., Cunningham, B. C., Fukunaga, R., Nagata, S., Goeddel, D. V., & Wells, J. A.
- Venue
- Science
- Published
- 1992-06-19
- Volume
- 256
- Issue
- 5064
- Pages
- 1677-1680
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1988812517
- Cited by
- 631
- References
- 20
- FWCI
- 38.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.